By releasing the first universal bioink in 2016, CELLINK democratized the cost of entry for researchers around the world and played a major role in turning the then up-and-coming field of 3D bioprinting into the thriving $1 billion industry it is today. CELLINKs bioinks, bioprinters, software and services have enabled critical breakthroughs in a wide range of applications from 3D cell culturing to tissue engineering to drug development.
The world leader of reliable in vitro human tissue model innovation. MatTeks skin, ocular, oral, respiratory, and intestinal tissue models are used to assess safety and efficacy throughout the cosmetics, chemical, pharmaceutical, and household product industries. These advanced tissue models empower companies to achieve their goals of non-animal testing while lowering testing costs and providing human-relevant results.
With over 2,500 users, Nanoscribe develops and produces 3D printers and maskless lithography systems for microfabrication as well as specially developed printing materials and application-specific solution sets. The specialist for additive manufacturing of high-precision structures and objects on the nano-, micro- and mesoscale was founded in 2007 as a spin-off of the Karlsruhe Institute of Technology (KIT).
Founded in 2014, CYTENA deliver automated and highly efficient lab workflows for improved cell line development, microbiome, live cell imaging, liquid handling and omics applications that enable new discoveries in areas such as drug development and health care research. The CYTENA instruments are used in the cell line development workflows at a majority of the worlds top pharmaceutical companies.